MRD Monitoring in Acute Lymphoblastic Leukemia
0 Ansichten
• 06/15/23
0
0
Einbetten
administrator
Abonnenten
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare